Glia-Induced Reversible Disruption of Blood–Brain Barrier Integrity and Neuropathological Response of the Neurovascular Unit

Toxicologic Pathology

Volumn 39, Issue 1, 2011, Pages 172-185

  Willis, Colin L ^a  

^a UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

astrocyte; blood brain barrier; brain endothelial cell; circumventricular organ; claudin; microglia; tight junction

Indexed keywords

CLAUDIN;

ANIMAL; ANIMAL MODEL; AREA POSTREMA; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CELL JUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLIA; HUMAN; IMMUNOLOGY; METABOLISM; NEUROLOGIC DISEASE; PATHOLOGY; TIGHT JUNCTION; TRANSCYTOSIS; VASCULARIZATION;

ADHERENS JUNCTIONS; ANIMALS; AREA POSTREMA; BLOOD-BRAIN BARRIER; BRAIN; CLAUDINS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MODELS, ANIMAL; NERVOUS SYSTEM DISEASES; NEUROGLIA; TIGHT JUNCTIONS; TRANSCYTOSIS;

EID: 79959517651     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310385830     Document Type: Article

References (74)

1. Abbott N. J. (2002). Astrocyte-endothelial interactions and blood–brain barrier permeability. J Anat 200, 629–38.
2. Abbott N. J. Ronnback L. Hansson E. (2006). Astrocyte-endothelial interactions at the blood–brain barrier. Nature Rev 7, 41–53.
3. Antonetti D. A. Barber A. J. Khin S. Lieth E. Tarbell J. M. Gardner T. W. (1998). Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47, 1953–959.
4. Arthur F. E. Shivers R. R. Bowman P. D. (1987). Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model. Brain Res 433, 155–59.
5. Banks W. A. (2010). Mouse models of neurological disorders: a view from the blood–brain barrier. Biochim Biophysia Acta 1802, 881–88.
6. Bazzoni G. Dejana E. (2004). Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis. Physiol Rev 84, 869–901.
7. Bushell T. J. Plevin R. Cobb S. Irving A. (2006). Characterization of proteinase- activated receptor 2 signalling and expression in rat hippocampal neurones and astrocytes. Neuropharmacology 50, 714–25.
8. Butt A. M. Jones H. C. Abbott N. J. (1990). Electrical-resistance across the blood–brain-barrier in anesthetized rats—a developmental study. J Physiol 429, 47–62.
9. Caley D. W. Maxwell D. S. (1970). Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J Comp Neurol 138, 31–47.
10. Cattelino A. Liebner S. Gallini R. Zanetti A. Balconi G. Corsi A. Bianco P. Wolburg H. Moore R. Oreda B. Kemler R. Dejana E. (2003). The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162, 1111–22.
11. Colognato H. Yurchenco P. D. (2000). Form and function: The laminin family of heterotrimers. Dev Dyn 218, 213–34.
12. Dermietzel R. Leibstein A. G. (1978). The microvascular pattern and perivascular linings of the area postrema. Cell Tissue Res 186, 97–110.
13. Didier N. Romero I. A. Creminon C. Wijkhuisen A. Grassi J. Mabondzo A. (2003). Secretion of interleukin-1β by astrocytes mediates endothelin-1 and tumour necrosis factor-α effects on human brain microvascular endothelial cell permeability. J Neurochem 86, 246–54.
14. Dohgu S. Yamauchi A. Takata F. Naito M. Tsuruo T. Higuchi S. Sawada Y. Kataoka Y. (2004). Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol 24, 491–97.
15. Dong Y. Benveniste E. N. (2001). Immune function of astrocytes. Glia 36, 180–90.
16. Dzwonek J. Rylski M. Kaczmarek L. (2004). Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567, 129–35.
17. Ellison D. Love S. Chimelli L. Harding B. N. Lowe J. Vinters H. V. (2003). Neuropathology: A reference text of CNS pathology, 2nd ed., pp. 549–84, Mosby, USA.
18. Feng J. Misu T. Fujihara K. Sakoda S. Nakatsuji Y. Fukaura H. Kikuchi S. Tashiro K. Suzumura A. Ishii N. Sugamura K. Nakashima I. Itoyama Y. (2004). Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis. Mult Scler 10, 494–98.
19. Ferrell W. R. Lockhart J. C. Kelso E. B. Dunning L. Plevin R. Meek S. E. Smith A. J. Hunter G. D. McLean J. S. McGarry F. Ramage R. Jiang L. Kanke T. Kawagoe J. (2003). Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111, 35–41.
20. Furuse M. Fujita K. Hiiragi T. Fujimoto K. Tsukita S. (1998). Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141, 1539–50.
21. Furuse M. Hirase T. Itoh M. Nagafuchi A. Yonemura S. Tsukita S. Tsukita S. (1993). Occludin—a novel integral membrane-protein localizing at tight junctions. J Cell Biol 123, 1777–88.
22. L.E., Goehler, A., Erisir, R.R.A., Gaykema, Neural-immune interface in the rat area postrema, Neuroscience, (2006), 140, 1415-1434
23. Guo L.-H. Schluesener H. J. (2006). Acute but not chronic stimulation of glial cells in rat spinal cord by systemic injection of lipopolysaccharide is associated with hyperalgesia. Acta Neuropathol 112, 703–13.
24. Guo L.-H. Schluesener H. J. (2007). The innate immunity of the central nervous system in chronic pain: The role of Toll-like receptors. Cell Mol Life Sci 64, 1128–36.
25. Hansson E. Ronnback L. (2003). Glial neuronal signaling in the central nervous system. FASEB J 17, 341–48.
26. Hartmann C. Zozulya A. Wegener J. Galla H-J. (2007). The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: An in vitro study. Exp Cell Res 313, 1318–25.
27. Hawkins B. T. Davis T. P. (2005). The blood–brain barrier/neurovascular unit in health and disease. Pharmacology Reviews 57, 173–85.
28. Hawkins R. A. O’Kane R. L. Simpson I. A. Vina J. R. (2006). Structure of the blood–brain barrier and its role in the transport of amino acids. J Nutr 136, 218S–26S.
29. Hirase T. Staddon J.M. Saitou M. Ando-Akatsuka Y. Itoh M. Furuse M. Fujimoto K. Tsukita S. Rubin L. L. (1997). Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 110, 1603–13.
30. Ibuki T. Matsumura K. Yamazaki Y. Nozaki T. Tanaka Y. Kobayashi S. (2003). Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J Neurochem 86, 318–28.
31. Janzer R. C. Raff M. C. (1987). Astrocytes induce blood–brain-barrier properties in endothelial-cells. Nature 325, 253–57.
32. Kawabata A. Kuroda R. Minami T. Kataoka K. Taneda M. (1998). Increased vascular permeability by a specific agonist of protease activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 125, 419–22.
33. Kelso E. B. Lockhart J. C. Hembrough T. Dunning L. Plevin R. Hollenberg M. D. Sommerhoff C. P. McLean J. S. Ferrell W. R. (2006). Therapeutic promise of proteinase-activated receptor-2 antagonist in joint inflammation. J Pharmacol Exp Ther 316, 1017–24.
34. Kielian T. (2006). Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83, 711–30.
35. Kishi Y. Ohta S. Kasuya N. Sakita S. Ashikaga T. Isobe M. (2001). Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovasc Drug Rev 19, 215–25.
36. Kniesel U. Wolburg H. (2000). Tight junctions of the blood–brain barrier. Cell Mol Neurobiol 20, 57–76.
37. Krum J. M. (1994). Experimental gliopathy in the adult-rat CNS—effect on the blood–spinal cord barrier. Glia 11, 354–66.
38. Lampugnani M. G. Dejana E. (2007). Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb Res 120, S1–6.
39. Levin A. A. Miller R. K. (1981). Fetal toxicity of cadmium in the rat: Decreased utero-placental blood flow. Tox Appl Pharm 58, 297–306.
40. Loescher W. Potschka H. (2005). Blood–brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2, 86– 98.
41. Martin-Padura I. Lostaglio S. Schneemann M. Williams L. Romano M. Fruscella P. Panzeri C. Stoppacciaro A. Ruco L. Villa A. Simmons D. Dejana E. (1998). Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142, 117–27.
42. Mizuno T. Kurotani T. Komatsu Y. Kawanokuchi J. Kato H. Mitsuma N. Suzumura A. (2004). Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46, 404–11.
43. Murabe Y. Nishida K. Sano Y. (1981). Cells capable of uptake of horseradish peroxidase in some circumventricular organs of the cat and rat. Cell Tissue Res 219, 85–92.
44. Noorbakhsh F. Tsutsui S. Vergnolle N. Boven L.A. Shariat N. Vodjgani M. Warren K.G. Andrade-Gordon P. Hollenberg M.D. Power C. (2006). Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203, 425–35.
45. Pardridge W. M. (2007). Blood–brain barrier delivery. Drug Discov Today 12, 54–61.
46. Paxinos G. Watson C. (1998). The Rat Brain in Stereotaxic Coordinates, 4th ed. San Diego, CA: Academic Press.
47. Pekny M. Nilsson M. (2005). Astrocyte activation and reactive gliosis. Glia 50, 427–34.
48. Petty M. A. Lo E. H. (2002). Junctional complexes of the blood–brain barrier: Permeability changes in neuroinflammation. Prog Neurobiol 68, 311–23.
49. Plumb J. McQuaid S. Mirakhur M. Kirk J. (2002). Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 12, 154–69.
50. Prat A. Biernacki K. Wosik K. Antel J. P. (2001). Glial cell influence on the human blood–brain barrier. Glia 36, 145–55.
51. M.M.W., Prior, A.M., Brown, G., Mavroudis, T., Lister, D.E., Ray, MRI characterization of a novel model of focal astrocyte loss, MAGMA, (2004), 17, 125-132
52. Raghavendra V. Tanga F. Y. DeLeo J. A. (2004). Complete Freund’s adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20, 467–73.
53. Rascher G. Fischmann A. Kroger S. Duffner F. Grote E. H. Wolburg H. (2002). Extracellular matrix and the blood–brain barrier in glioblastoma multiforme: Spatial segregation of tenascin and agrin. Acta Neuropathol (Berl) 104, 85–91.
54. Ray D.E. (1982). Changes in blood flow associated with deltamethrin-induced choreoathetosis in the rat. Exp Brain Res 45, 269–76.
55. Rodier R. M. (1995). Developing brain as a target of toxicity. Environ Health Perspect 103, 73–76.
56. Rubin L. L. Barbu K. Bard F. Cannon C. Hall D. E. Horner H. Janatpour M. Liaw C. Manning K. Morales J. Porter S. Tanner L. Tomaselli K. Yednock T. (1991). Differentiation of brain endothelial cells in cell culture. Ann NY Acad Sci 633, 420–25.
57. Sano Y. Murabe Y. (1980). Morphological and functional peculiarities of mesenchymal cells in the pars tuberalis of the pituitary gland. Cell Tissue Res 206, 171–80.
58. Shimizu N. Ishii S. (1964). Fine structure of the area postrema of the rabbit brain. Z Zellforsch Mikrosk Anat 64, 462–73.
59. Sobue K. Yamamoto N. Yoneda K. Hodgson M. E. Yamashiro K. Tsuruoka N. Tsuda T. Katsuya H. Miura Y. Asai K. Kato T. (1999). Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 35, 155–64.
60. Stoll G. Jander S. (1999). The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58, 233–47.
61. Suzumura A. Ito A. Yoshikawa M. Sawada M. (1999). Ibudilast suppresses TNF alpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res 837, 203–12.
62. Szabo A. Kalman M. (2004). Disappearance of the post-lesional laminin immunopositivity of brain vessels is parallel with the formation of gliovascular junctions and common basal lamina. A double-labelling immunohistochemical study. Neuropathol Appl Neurobiol 30, 169–77.
63. Tikka T. Fiebich B. L. Goldsteins G. Keinanen R. Koistinaho J. (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21, 2580–88.
64. Tsukita S. Furuse M. Itoh M. (2001). Multifunctional strands in tight junctions. Nature Rev Mol Cell Biol 2, 285–93.
65. van Horssen J. Bo L. Dijkstra C. D. de Vries H. E. (2006). Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis 24, 484–91.
66. Vergnolle N. Hollenberg M. D. Sharkey K. A. Wallace J. L. (1999). Characterisation of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 127, 1083–90.
67. Willis C. L. Davis T. P. (2008). Chronic inflammatory pain and the neurovascular unit: A central role for glia in maintaining BBB integrity. Curr Pharm Design 14, 1625–43.
68. Willis C. L. Garwood C. J. Ray D. E. (2007). A size-selective vascular barrier in the rat area postrema formed by perivascular macrophages and the extracellular matrix. Neuroscience 150, 498–509.
69. Willis C. L. Leach L. Clarke G. J. Nolan C. C. Ray D. E. (2004a). Reversible disruption of tight junction complexes in the rat blood–brain barrier, following transitory focal astrocyte loss. Glia 48, 1–13.
70. Willis C. L. Meske D. S. Davis T. P. (2010). Protein kinase C activation modulates reversible increase in cortical blood–brain barrier permeability and tight junction protein expression during hypoxia and post-hypoxic reoxygenation. J Cereb Blood Flow Metab 30, 1847–59.
71. C.L., Willis, C.C., Nolan, S.N., Reith, T., Lister, C.J., Guerin, G., Mavroudis, M.M.W., Prior, D.E., Ray, Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood–brain barrier in the apparent absence of direct astrocytic contact, Glia, (2004), 45, 325-337
72. Wolburg H. Lippoldt A. (2002). Tight junctions of the blood–brain barrier: Development, composition and regulation. Vasc Pharmacol 38, 323–37.
73. Wolka A. M. Huber J. D. Davis T. P. (2003). Pain and the blood brain barrier: Obstacles to drug delivery. Adv Drug Deliv Rev 55, 987–1006.
74. Yenari M. A. Xu L. Tang X. N. Qiao Y. Giffard R. G. (2006). Microglia potentiate damage to blood–brain barrier constituents: Improvement by minocycline in vivo and in vitro. Stroke 37, 1087–93.